Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 1/2014

01-03-2014

Endocrine Pathology of the Ovary

In Tribute to Robert E Scully, MD

Authors: Esther Oliva, Robert H. Young

Published in: Endocrine Pathology | Issue 1/2014

Login to get access

Excerpt

It is a pleasure and honor to be asked to contribute to this anniversary issue of the journal. Although tinged with sadness, it is fortuitous we were asked to write on the endocrine pathology of the ovary. This is the very same title as the wonderful book on the ovary written by our mentor, Dr. Robert E. Scully, with a gynecologist Dr. J.M Morris, in the mid 1950s and published in 1958 [1]. We began to work on this issue on Dr. Scully’s birthday, August 31, the first since his death in late October 2012, and the day, and time since working on this essay, has produced much reflection. We dedicate these pages to Dr. Scully knowing he would be happy we are focusing on an area of ovarian pathology of great interest to him. …
Literature
1.
Morris JM, Scully RE: Endocrine Pathology of the Ovary, St. Louis: C. V. Mosby Co., 1958.
2.
Scully RE, Young RH, Clement PB: Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Washington: Armed Forces Institute of Pathology, 1996.
3.
Scully RE, Morris JM. Functioning ovarian tumors. In: Meigs JV, Surgis S, eds. Progress in Gynecology. New York: Grune and Stratton, 1957; 20-34.
4.
Scully RE. Gonadoblastoma; a gonadal tumor related to the dysgerminoma (seminoma) and capable of sex-hormone production. Cancer 6: 455-463, 1953.PubMed
5.
Scully RE. Gonadoblastoma. A review of 74 cases. Cancer 25: 1340-1356, 1970.PubMed
6.
Scully RE, Richardson GS. Luteinization of the stroma of metastatic cancer involving the ovary and its endocrine significance. Cancer 14: 827-840, 1961.PubMed
7.
Benedict PH, Cohen RB, Cope O, Scully RE. Ovarian and adrenal morphology in cases of hirsutism or virilism and Stein–Leventhal syndrome. Fertil Steril 13: 380-395, 1962.PubMed
8.
Boss JH, Scully RE, Wegner KH, Cohen RB. Structural variations in the adult ovary. Clinical significance. Obstet Gynecol 25: 747-764, 1965.
9.
Herrington JB, Scully RE. Endocrine aspects of germ cell tumors. In: Damjanov I, Knowles DM, Solter D, eds. The Human Teratomas. Clifton, NJ: Humana, 1983; 215-229.
10.
Rutgers JL, Scully RE. Functioning ovarian tumors with peripheral steroid cell proliferation: a report of twenty-four cases. Int J Gynecol Pathol 5: 319-337, 1986.PubMed
11.
Scully RE. Androgenic lesions of the ovary. In: Grady HG, Smith OE (eds) The Ovary. Baltimore: Williams & Wilkins Co., 1962; 143-174.
12.
Scully RE. Germ cell tumors of the ovary and fallopian tube. In: Meigs JV, Surgis S, eds. Progress in Gynecology. New York: Grune & Stratton, 1963; 335-347.
13.
Scully RE. Ovarian tumors with endocrine manifestations. In: DeGroot LJ, ed. Metabolic Basis of Endocrinology. Philadelphia: W. B. Saunders Co., 1989; 1994-2008.
14.
Scully RE. Stromal Luteoma of the Ovary. A Distinctive Type of Lipoid-Cell Tumor. Cancer 17: 769-778, 1964.PubMed
15.
Scully RE, Cohen RB. Oxidative-Enzyme Activity in Normal and Pathologic Human Ovaries. Obstet Gynecol 24: 667-681, 1964.PubMed
16.
Scully RE. Ovarian tumors with functioning stroma. In: Fox H, Wells M, eds. Haines and Taylor’s Gynaecological and Obstetrical Pathology. 3rd ed. Edinburgh: Churchill Livingstone, 1987; 724-736.
17.
Aguirre P, Scully RE, Wolfe HJ, DeLellis RA. Argyrophil cells in Brenner tumors: histochemical and immunohistochemical analysis. Int J Gynecol Pathol 5: 223-234, 1986.PubMed
18.
Aguirre P, Thor AD, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. An immunohistochemical study. Int J Gynecol Pathol 8: 364-373, 1989.PubMed
19.
Kommoss F, Oliva E, Bhan AK, Young RH, Scully RE. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod Pathol 11: 656-664, 1998.PubMed
20.
Scully RE, Aguirre P, DeLellis RA. Argyrophilia, serotonin, and peptide hormones in the female genital tract and its tumors. Int J Gynecol Pathol 3: 51-70, 1984.PubMed
21.
Scully RE. Immunohistochemistry of ovarian tumors. In: Russo J, Russo I, eds. Immunocytochemistry in Tumor Diagnosis. Boston: Martinus Nijhoff, 1985; 293-320.
22.
Stewart CJ, Jeffers MD, Kennedy A. Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histological mimics. Histopathology 31: 67-74, 1997.PubMed
23.
Lugli A, Forster Y, Haas P, et al. . Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples. Hum Pathol 34: 994-1000, 2003.PubMed
24.
McCluggage WG, Maxwell P. Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours. Histopathology 38: 403-408, 2001.PubMed
25.
Krug E, Berga SL. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary. Obstet Gynecol 99: 893-897, 2002.PubMed
26.
Sasano H, Fukunaga M, Rojas M, Silverberg SG. Hyperthecosis of the ovary. Clinicopathologic study of 19 cases with immunohistochemical analysis of steroidogenic enzymes. Int J Gynecol Pathol 8: 311-320, 1989.PubMed
27.
Vollaard ES, van Beek AP, Verburg FA, Roos A, Land JA. Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin. J Clin Endocrinol Metab 96: 1197-1201, 2011.PubMed
28.
Kurman RJ, Carcangiu ML, Herrington CS, Young RH: WHO Classification of Tumours of Female Reproductive Organs. Lyon: International Agency for Research on Cancer, 2013 (in press).
29.
Meldrum DR, Frumar AM, Shamonki IM, Benirschke K, Judd HL. Ovarian and adrenal steroidogenesis in a virilized patient with gonadotropin-resistant ovaries and hilus cell hyperplasia. Obstet Gynecol 56: 216-221, 1980.PubMed
30.
Hofland M, Cosyns S, De Sutter P, Bourgain C, Velkeniers B. Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases. Gynecol Endocrinol 29: 213-215, 2013.PubMed
31.
Cao QJ, Jones JG, Li M. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol 20: 346-352, 2001.PubMed
32.
Bamberger AM, Ivell R, Balvers M, et al. . Relaxin-like factor (RLF): a new specific marker for Leydig cells in the ovary. Int J Gynecol Pathol 18: 163-168, 1999.PubMed
33.
Young RH, Scully RE. Fibromatosis and massive edema of the ovary, possibly related entities: a report of 14 cases of fibromatosis and 11 cases of massive edema. Int J Gynecol Pathol 3: 153-178, 1984.PubMed
34.
Yamoto M, Minami S, Nakano R. Immunohistochemical localization of inhibin subunits in polycystic ovary. J Clin Endocrinol Metab 77: 859-862, 1993.PubMed
35.
Duleba AJ, Pehlivan T, Carbone R, Spaczynski RZ. Activin stimulates proliferation of rat ovarian thecal–interstitial cells. Biol Reprod 65: 704-709, 2001.PubMed
36.
Kosloske AM, Goldthorn JF, Kaufman E, Hayek A. Treatment of precocious pseudopuberty associated with follicular cysts of the ovary. Am J Dis Child 138: 147-149, 1984.PubMed
37.
Scully RE, Mark EJ, McNeely WF, McNeely BU. Case Records of the Massachusetts General Hospital, Case 47-1989. N Engl J Med 321: 1463-1471, 1989.
38.
McCluggage WG, Patterson A, White J, Anderson NH. Immunocytochemical staining of ovarian cyst aspirates with monoclonal antibody against inhibin. Cytopathology 9: 336-342, 1998.PubMed
39.
Scully RE, McNeely BU. Case Records of the Massachusetts General Hospital, Case 4-1975. N Engl J Med 202: 199-203, 1975.
40.
Lumbroso S, Paris F, Sultan C. Activating Gsalpha mutations: analysis of 113 patients with signs of McCune–Albright syndrome—a European Collaborative Study. J Clin Endocrinol Metab 89: 2107-2113, 2004.PubMed
41.
de Sanctis C, Lala R, Matarazzo P, Andreo M, de Sanctis L. Pubertal development in patients with McCune–Albright syndrome or pseudohypoparathyroidism. J Pediatr Endocrinol Metab 16 Suppl 2: 293-296, 2003.PubMed
42.
Clement PB, Scully RE. Large solitary luteinized follicle cyst of pregnancy and puerperium: A clinicopathological analysis of eight cases. Am J Surg Pathol 4: 431-438, 1980.PubMed
43.
Fang YM, Gomes J, Lysikiewicz A, Maulik D. Massive luteinized follicular cyst of pregnancy. Obstet Gynecol 105: 1218-1221, 2005.PubMed
44.
Wang XY, Vinta MK, Myers S, Fan F. Solitary luteinized follicle cyst of pregnancy and puerperium. Pathol Res Pract 202: 471-473, 2006.PubMed
45.
Angioni S, Portoghese E, Milano F, Melis GB, Fulghesu AM. Hirsutism and hyperandrogenism associated with hyperreactio luteinalis in a singleton pregnancy: a case report. Gynecol Endocrinol 23: 248-251, 2007.PubMed
46.
47.
Masarie K, Katz V, Balderston K. Pregnancy luteomas: clinical presentations and management strategies. Obstet Gynecol Surv 65: 575-582, 2010.PubMed
48.
Mazza V, Di Monte I, Ceccarelli PL, et al. . Prenatal diagnosis of female pseudohermaphroditism associated with bilateral luteoma of pregnancy: case report. Hum Reprod 17: 821-824, 2002.PubMed
49.
Spitzer RF, Wherrett D, Chitayat D, et al. . Maternal luteoma of pregnancy presenting with virilization of the female infant. J Obstet Gynaecol Can 29: 835-840, 2007.PubMed
50.
Wang YC, Su HY, Liu JY, Chang FW, Chen CH. Maternal and female fetal virilization caused by pregnancy luteomas. Fertil Steril 84: 509, 2005.PubMed
51.
Clement PB. Tumor-like lesions of the ovary associated with pregnancy. Int J Gynecol Pathol 12: 108-115, 1993.PubMed
52.
Norris HJ, Taylor HB. Nodular theca-lutein hyperplasia of pregnancy (so-called “pregnancy luteoma”). A clinical and pathologic study of 15 cases. Am J Clin Pathol 47: 557-566, 1967.PubMed
53.
Burandt E, Young RH. Pregnancy Luteoma: A study of 20 cases on the occasion of the 50th anniversary of its description by Dr. William H. Sternberg, with an emphasis on the common presence of follicle-like spaces and their diagnostic implications. Am J Surg Pathol, 2013 (in press).
54.
Bjorkholm E, Silfversward C. Theca-cell tumors. Clinical features and prognosis. Acta Radiol Oncol 19: 241-244, 1980.PubMed
55.
Roth LM, Czernobilsky B. Perspectives on pure ovarian stromal neoplasms and tumor-like proliferations of the ovarian stroma. Am J Surg Pathol 35: e15-33, 2011.PubMed
56.
Irving JA, Young RH. Granulosa cell tumors of the ovary with a pseudopapillary pattern: a study of 14 cases of an unusual morphologic variant emphasizing their distinction from transitional cell neoplasms and other papillary ovarian tumors. Am J Surg Pathol 32: 581-586, 2008.PubMed
57.
Irving JA, Young RH. Microcystic stromal tumor of the ovary: report of 16 cases of a hitherto uncharacterized distinctive ovarian neoplasm. Am J Surg Pathol 33: 367-375, 2009.PubMed
58.
Oliva E, Egger JF, Young RH. Primary endometrioid stromal sarcoma of the ovary: A clinicopathological study of 27 cases with morphologic and behavioral features similar to those of uterine low-grade endometrial stromal sarcoma. Am J Surg Pathol, 2013 (in press).
59.
Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases. Am J Surg Pathol 26: 1477-1483, 2002.PubMed
60.
Johnson AL, Tilly JL, Levorse JM. Possible role for arachidonic acid in the control of steroidogenesis in hen theca. Biol Reprod 44: 338-344, 1991.PubMed
61.
Kawasaki H, Kretsinger RH. Calcium-binding proteins. 1: EF-hands. Protein Profile 1: 343-517, 1994.PubMed
62.
Zhang M, Kao CS, Ulbright TM, Epstein JI. Testicular fibrothecoma: a morphologic and immunohistochemical study of 16 cases. Am J Surg Pathol 37: 1208-1214, 2013.PubMed
63.
Al-Agha OM, Huwait HF, Chow C, et al. . FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 35: 484-494, 2011.PubMed
64.
Shah SP, Kobel M, Senz J, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 360: 2719-2729, 2009.PubMed
65.
Micci F, Haugom L, Abeler VM, Trope CG, Danielsen HE, Heim S. Consistent numerical chromosome aberrations in thecofibromas of the ovary. Virchows Arch 452: 269-276, 2008.PubMed
66.
Roth LM, Sternberg WH. Partly luteinized theca cell tumor of the ovary. Cancer 51: 1697-1704, 1983.PubMed
67.
Zhang J, Young RH, Arseneau J, Scully RE. Ovarian stromal tumors containing lutein or Leydig cells (luteinized thecomas and stromal Leydig cell tumors)—a clinicopathological analysis of fifty cases. Int J Gynecol Pathol 1: 270-285, 1982.PubMed
68.
Scully RE, Galdabini JJ, McNeely BU. Case Records of the Massachusetts General Hospital, Case 10-1980. N Engl J Med 302: 621-626, 1980.
69.
Sternberg WH, Roth LM. Ovarian stromal tumors containing Leydig cells. I. Stromal–Leydig cell tumor and non-neoplastic transformation of ovarian stroma to Leydig cells. Cancer 32: 940-951, 1973.PubMed
70.
McCluggage WG, Singh N, Kommoss S, Huntsman DG, Gilks CB. Ovarian Cellular Fibromas Lack FOXL2 Mutations: A Useful Diagnostic Adjunct in the Distinction From Diffuse Adult Granulosa Cell Tumor. Am J Surg Pathol 37: 1450-1455, 2013.PubMed
71.
Zhao C, Vinh TN, McManus K, Dabbs D, Barner R, Vang R. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am J Surg Pathol 33: 354-366, 2009.PubMed
72.
Chalvardjian A, Scully RE. Sclerosing stromal tumors of the ovary. Cancer 31: 664-670, 1973.PubMed
73.
Cashell AW, Cohen ML. Masculinizing sclerosing stromal tumor of the ovary during pregnancy. Gynecol Oncol 43: 281-285, 1991.PubMed
74.
Duska LR, Flynn C, Goodman A. Masculinizing sclerosing stromal cell tumor in pregnancy: report of a case and review of the literature. Eur J Gynaecol Oncol 19: 441-443, 1998.PubMed
75.
Quinn MA, Oster AO, Fortune D, Hudson B. Sclerosing stromal tumour of the ovary case report with endocrine studies. Br J Obstet Gynaecol 88: 555-558, 1981.PubMed
76.
Staats PN, McCluggage WG, Clement PB, Young RH. Luteinized thecomas (thecomatosis) of the type typically associated with sclerosing peritonitis: a clinical, histopathologic, and immunohistochemical analysis of 27 cases. Am J Surg Pathol 32: 1273-1290, 2008.PubMed
77.
Walker J, Moss EL, Ganesan R, Hirschowitz L. Sclerosing peritonitis associated with a luteinized adult granulosa cell tumor. Int J Gynecol Pathol 31: 141-144, 2012.PubMed
78.
Vang R, Bague S, Tavassoli FA, Prat J. Signet-ring stromal tumor of the ovary: clinicopathologic analysis and comparison with Krukenberg tumor. Int J Gynecol Pathol 23: 45-51, 2004.PubMed
79.
Maeda D, Shibahara J, Sakuma T, et al. Beta-catenin (CTNNB1) S33C mutation in ovarian microcystic stromal tumors. Am J Surg Pathol 35: 1429-1440, 2011.PubMed
80.
Young RH, Dickersin GR, Scully RE. Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol 8: 575-596, 1984.PubMed
81.
Zaloudek C, Norris HJ. Granulosa tumors of the ovary in children: a clinical and pathologic study of 32 cases. Am J Surg Pathol 6: 503-512, 1982.PubMed
82.
Nakashima N, Young RH, Scully RE. Androgenic granulosa cell tumors of the ovary. A clinicopathologic analysis of 17 cases and review of the literature. Arch Pathol Lab Med 108: 786-791, 1984.PubMed
83.
Geerts I, Vergote I, Neven P, Billen J. The role of inhibins B and antimullerian hormone for diagnosis and follow-up of granulosa cell tumors. Int J Gynecol Cancer 19: 847-855, 2009.PubMed
84.
Ganesan R, Hirschowitz L, Baltrusaityte I, McCluggage WG. Luteinized adult granulosa cell tumor—a series of 9 cases: revisiting a rare variant of adult granulosa cell tumor. Int J Gynecol Pathol 30: 452-459, 2011.PubMed
85.
Young RH, Oliva E, Scully RE. Luteinized adult granulosa cell tumors of the ovary: a report of four cases. Int J Gynecol Pathol 13: 302-310, 1994.PubMed
86.
Young RH, Scully RE. Ovarian sex cord-stromal tumors with bizarre nuclei: a clinicopathologic analysis of 17 cases. Int J Gynecol Pathol 1: 325-335, 1983.PubMed
87.
Ahmed E, Young RH, Scully RE. Adult granulosa cell tumor of the ovary with foci of hepatic cell differentiation: a report of four cases and comparison with two cases of granulosa cell tumor with Leydig cells. Am J Surg Pathol 23: 1089-1093, 1999.PubMed
88.
Nogales FF, Concha A, Plata C, Ruiz-Avila I. Granulosa cell tumor of the ovary with diffuse true hepatic differentiation simulating stromal luteinization. Am J Surg Pathol 17: 85-90, 1993.PubMed
89.
Young RH, Oliva E, Scully RE. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol 18: 1102-1116, 1994.PubMed
90.
McCluggage WG, Oliva E, Connolly LE, McBride HA, Young RH. An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol 23: 330-336, 2004.PubMed
91.
Kobel M, Gilks CB, Huntsman DG. Adult-type granulosa cell tumors and FOXL2 mutation. Cancer Res 69: 9160-9162, 2009.PubMed
92.
Kommoss S, Anglesio MS, Mackenzie R, et al. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines. Mod Pathol 26: 860-867, 2013.PubMed
93.
Rabban JT, Zaloudek CJ. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Histopathology 62: 71-88, 2013.PubMed
94.
Cathro HP, Stoler MH. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Hum Pathol 36: 195-201, 2005.PubMed
95.
Costa MJ, Ames PF, Walls J, Roth LM. Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool. Hum Pathol 28: 1247-1254, 1997.PubMed
96.
Deavers MT, Malpica A, Liu J, Broaddus R, Silva EG. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol 16: 584-590, 2003.PubMed
97.
Matias-Guiu X, Pons C, Prat J. Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Hum Pathol 29: 840-845, 1998.PubMed
98.
Riopel MA, Perlman EJ, Seidman JD, Kurman RJ, Sherman ME. Inhibin and epithelial membrane antigen immunohistochemistry assist in the diagnosis of sex cord-stromal tumors and provide clues to the histogenesis of hypercalcemic small cell carcinomas. Int J Gynecol Pathol 17: 46-53, 1998.PubMed
99.
Shah VI, Freites ON, Maxwell P, McCluggage WG. Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms. J Clin Pathol 56: 221-224, 2003.PubMedCentralPubMed
100.
Oliva E, Alvarez T, Young RH. Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol 29: 143-156, 2005.PubMed
101.
Tavassoli FA, Norris HJ. Sertoli tumors of the ovary. A clinicopathologic study of 28 cases with ultrastructural observations. Cancer 46: 2281-2297, 1980.PubMed
102.
Tracy SL, Askin FB, Reddick RL, Jackson B, Kurman RJ. Progesterone secreting Sertoli cell tumor of the ovary. Gynecol Oncol 22: 85-96, 1985.PubMed
103.
Young RH, Scully RE. Ovarian Sertoli–Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 9: 543-569, 1985.PubMed
104.
Gui T, Cao D, Shen K, et al. A clinicopathological analysis of 40 cases of ovarian Sertoli–Leydig cell tumors. Gynecol Oncol 127: 384-389, 2012.PubMed
105.
Hansen TP, Sorensen B. Sertoli–Leydig cell tumour of the ovary—a rare cause of virilization after menopause. APMIS 101: 663-666, 1993.PubMed
106.
Larsen WG, Felmar EA, Wallace ME, Frieder R. Sertoli–Leydig cell tumor of the ovary: a rare cause of amenorrhea. Obstet Gynecol 79: 831-833, 1992.PubMed
107.
Ohashi M, Hasegawa Y, Haji M, Igarashi M, Nawata H. Production of immunoreactive inhibin by a virilizing ovarian tumour (Sertoli–Leydig tumour). Clin Endocrinol (Oxf) 33: 613-618, 1990.
108.
Mango D, Scirpa P, Liberati M, Menini E, Fabiano A, Mancuso S. Ovarian and peripheral steroid hormones in a case of Sertoli–Leydig cell tumor. J Endocrinol Invest 11: 521-525, 1988.PubMed
109.
McCluggage WG, Young RH. Ovarian Sertoli–Leydig cell tumors with pseudoendometrioid tubules (pseudoendometrioid Sertoli–Leydig cell tumors). Am J Surg Pathol 31: 592-597, 2007.PubMed
110.
Mooney EE, Nogales FF, Bergeron C, Tavassoli FA. Retiform Sertoli–Leydig cell tumours: clinical, morphological and immunohistochemical findings. Histopathology 41: 110-117, 2002.PubMed
111.
Ching B, Klink A, Wang L. Pathologic quiz case: a 22-year-old woman with a large right adnexal mass. Poorly differentiated Sertoli–Leydig cell tumor of the right ovary with retiform differentiation and heterologous elements (mucinous components). Arch Pathol Lab Med 128: e93-95, 2004.PubMed
112.
Young RH, Prat J, Scully RE. Ovarian Sertoli-Leydig cell tumors with heterologous elements. I. Gastrointestinal epithelium and carcinoid: A clinicopathologic analysis of thirty-six cases. Cancer 50:2448-2456, 1982.
113.
Mooney EE, Nogales FF, Tavassoli FA. Hepatocytic differentiation in retiform Sertoli–Leydig cell tumors: distinguishing a heterologous element from Leydig cells. Hum Pathol 30: 611-617, 1999.PubMed
114.
Prat J, Young RH, Scully RE. Ovarian Sertoli–Leydig cell tumors with heterologous elements. II. Cartilage and skeletal muscle: a clinicopathologic analysis of twelve cases. Cancer 50: 2465-2475, 1982.PubMed
115.
Roth LM, Anderson MC, Govan AD, Langley FA, Gowing NF, Woodcock AS. Sertoli–Leydig cell tumors: a clinicopathologic study of 34 cases. Cancer 48: 187-197, 1981.PubMed
116.
Young RH, Perez-Atayde AR, Scully RE. Ovarian Sertoli–Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein. Am J Surg Pathol 8: 709-718, 1984.PubMed
117.
Zaloudek C, Norris HJ. Sertoli–Leydig tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol 8: 405-418, 1984.PubMed
118.
Young RH, Dudley AG, Scully RE. Granulosa cell, Sertoli–Leydig cell, and unclassified sex cord-stromal tumors associated with pregnancy: a clinicopathological analysis of thirty-six cases. Gynecol Oncol 18: 181-205, 1984.PubMed
119.
Chadha S, Honnebier WJ, Schaberg A. Raised serum alpha-fetoprotein in Sertoli–Leydig cell tumor (androblastoma) of ovary: report of two cases. Int J Gynecol Pathol 6: 82-88, 1987.PubMed
120.
Farley JH, Taylor RR, Bosscher JR. Late presentation of an alpha-fetoprotein secreting isolated large upper abdominal retroperitoneal Sertoli–Leydig cell tumor recurrence. Gynecol Oncol 56: 319-322, 1995.PubMed
121.
Gagnon S, Tetu B, Silva EG, McCaughey WT. Frequency of alpha-fetoprotein production by Sertoli–Leydig cell tumors of the ovary: an immunohistochemical study of eight cases. Mod Pathol 2: 63-67, 1989.PubMed
122.
Hammad A, Jasnosz KM, Olson PR. Expression of alpha-fetoprotein by ovarian Sertoli–Leydig cell tumors. Case report and review of the literature. Arch Pathol Lab Med 119: 1075-1079, 1995.PubMed
123.
Singh ZN, Singh MK, Chopra P. Sertoli–Leydig cell tumor with malignant heterologous elements and raised alpha-fetoprotein: a case report. J Obstet Gynaecol Res 22: 595-598, 1996.PubMed
124.
Tetu B, Ordonez NG, Silva EG. Sertoli–Leydig cell tumor of the ovary with alpha-fetoprotein production. Arch Pathol Lab Med 110: 65-68, 1986.PubMed
125.
Watanabe T, Yamada H, Morimura Y, Abe M, Motoyama T, Sato A. Ovarian Sertoli–Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha-fetoprotein: a case report. J Obstet Gynaecol Res 34: 418-421, 2008.PubMed
126.
Maillet D, Goulvent T, Rimokh R, et al. Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network. Gynecol Oncol, 2013. doi:10.​1016/​j.​ygyno.​2013.​10.​013
127.
Banno K, Kisu I, Yanokura M, et al. Hereditary gynecological tumors associated with Peutz–Jeghers syndrome (Review). Oncol Lett 6: 1184-1188, 2013.PubMedCentralPubMed
128.
Ishikawa H, Kiyokawa T, Takatani T, Wen WG, Shozu M. Giant multilocular sex cord tumor with annular tubules associated with precocious puberty. Am J Obstet Gynecol 206: e14-16, 2012.PubMed
129.
Shen K, Wu PC, Lang JH, Huang RL, Tang MT, Lian LJ. Ovarian sex cord tumor with annular tubules: a report of six cases. Gynecol Oncol 48: 180-184, 1993.PubMed
130.
Young RH, Welch WR, Dickersin GR, Scully RE. Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz–Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 50: 1384-1402, 1982.PubMed
131.
Hayes MC, Scully RE. Stromal luteoma of the ovary: a clinicopathological analysis of 25 cases. Int J Gynecol Pathol 6: 313-321, 1987.PubMed
132.
Paraskevas M, Scully RE. Hilus cell tumor of the ovary. A clinicopathological analysis of 12 Reinke crystal-positive and nine crystal-negative cases. Int J Gynecol Pathol 8: 299-310, 1989.PubMed
133.
Busam KJ, Iversen K, Coplan KA, et al. Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol 22: 57-63, 1998.PubMed
134.
Deavers MT, Malpica A, Ordonez NG, Silva EG. Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin. Int J Gynecol Pathol 22: 162-167, 2003.PubMed
135.
Jones MW, Harri R, Dabbs DJ, Carter GJ. Immunohistochemical profile of steroid cell tumor of the ovary: a study of 14 cases and a review of the literature. Int J Gynecol Pathol 29: 315-320, 2010.PubMed
136.
Rishi M, Howard LN, Bratthauer GL, Tavassoli FA. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 21: 583-589, 1997.PubMed
137.
Palmer PE, Bogojavlensky S, Bhan AK, Scully RE. Prolactinoma in wall of ovarian dermoid cyst with hyperprolactinemia. Obstet Gynecol 75: 540-543, 1990.PubMed
138.
Oliva E, Andrada E, Pezzica E, Prat J. Ovarian carcinomas with choriocarcinomatous differentiation. Cancer 72: 2441-2446, 1993.PubMed
139.
Matias-Guiu X, Prat J. Ovarian tumors with functioning stroma. An immunohistochemical study of 100 cases with human chorionic gonadotropin monoclonal and polyclonal antibodies. Cancer 65: 2001-2005, 1990.PubMed
140.
Kiyokawa T, Young RH, Scully RE. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 30: 277-299, 2006.PubMed
141.
Rutgers JL, Scully RE. Cysts (cystadenomas) and tumors of the rete ovarii. Int J Gynecol Pathol 7: 330-342, 1988.PubMed
142.
Clement PB, Young RH, Scully RE. Clinical syndromes associated with tumors of the female genital tract. Semin Diagn Pathol 8: 204-233, 1991.PubMed
143.
Abeler V, Kjorstad KE, Nesland JM. Small cell carcinoma of the ovary. A report of six cases. Int J Gynecol Pathol 7: 315-329, 1988.PubMed
144.
Aguirre P, Thor AD, Scully RE. Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings. Am J Clin Pathol 92: 140-149, 1989.PubMed
145.
Walt H, Hornung R, Fink D, et al. Hypercalcemic-type of small cell carcinoma of the ovary: characterization of a new tumor line. Anticancer Res 21: 3253-3259, 2001.PubMed
146.
Burton PB, Knight DE, Quirke P, Smith R, Moniz C. Parathyroid hormone related peptide in ovarian carcinoma. J Clin Pathol 43: 784, 1990.PubMedCentralPubMed
147.
Chen L, Dinh TA, Haque A. Small cell carcinoma of the ovary with hypercalcemia and ectopic parathyroid hormone production. Arch Pathol Lab Med 129: 531-533, 2005.PubMed
148.
Matias-Guiu X, Prat J, Young RH, et al. Human parathyroid hormone-related protein in ovarian small cell carcinoma. An immunohistochemical study. Cancer 73: 1878-1881, 1994.PubMed
149.
Watson J, Taylor M, Pampiglione J, Rasbridge S, Armitage M. An exception to the rule: ectopic ACTH production from functional neuroendocrine tissue in an ovarian dermoid cyst. J Endocrinol Invest 24: 802-805, 2001.PubMed
150.
Schlaghecke R, Kreuzpaintner G, Burrig KF, Juli E, Kley HK. Cushing’s syndrome due to ACTH-production of an ovarian carcinoid. Klin Wochenschr 67: 640-644, 1989.PubMed
151.
Korzets A, Nouriel H, Steiner Z, et al. Resistant hypertension associated with a renin-producing ovarian Sertoli cell tumor. Am J Clin Pathol 85: 242-247, 1986.PubMed
Metadata
Title
Endocrine Pathology of the Ovary
In Tribute to Robert E Scully, MD
Authors
Esther Oliva
Robert H. Young
Publication date
01-03-2014
Publisher
Springer US
Published in
Endocrine Pathology / Issue 1/2014
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-013-9285-4

Other articles of this Issue 1/2014

Endocrine Pathology 1/2014 Go to the issue

OriginalPaper

Follicular-Patterned Afflictions of the Thyroid Gland: Reappraisal of the Most Discussed Entity in Endocrine Pathology

EditorialNotes

Editorial: The Birth of Endocrine Pathology

OriginalPaper

Neuroendocrine Tumors of the Pancreas: Current Concepts and Controversies

OriginalPaper

25 Years of Neuroendocrine Neoplasms of the Gastrointestinal Tract

OriginalPaper

The Adrenal Medulla and Extra-adrenal Paraganglia: Then and Now

OriginalPaper

Pancreatic Pathology in Type 1 Diabetes Mellitus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits